Skip navigation

Calls to Action

Stephen Scherer

Research co-funded by Autism Speaks promises to improve early identification of autism and identify biological targets for treatment
May 25, 2014

 

Researchers funded by Autism Speaks have helped devise a “genetic formula” that promises to improve the accuracy of early screening for autism and speed the identification of biological targets for future treatments.

Discoveries support CNV genetic testing for personalized diagnosis and treatment of autism subtypes and associated medical conditions
April 24, 2014

(April 24, 2014) Researchers with the Autism Genome Project are calling for the broad use of a relatively new type of genetic test – for copy number variants (CNVs) – as the next step in individualized diagnosis and treatment of autism.

Definitive Look at Inherited and De Novo Genetic Mutations and Risk Genes Found in Half of the Families Tested Holds Promise for Future Diagnosis, Prevention and Treatment

A collaborative formed by Autism Speaks has sequencing entire genome of individuals with autism and their family members.

July 11, 2013

NEW YORK, N.Y., (July 11, 2013) – A collaborative formed by Autism Speaks, the world’s leading autism science and advocacy organization, has found full genome sequencing examining the entire DNA code of individuals with autism spectrum disorder (ASD) and their family members to provide the definitive look at the wide ranging genetic variations associated with ASD.